Innovent Biologics, Inc. (HKG:1801)
49.95
+0.55 (1.11%)
May 13, 2025, 3:45 PM HKT
Innovent Biologics Employees
Innovent Biologics had 5,659 employees as of December 31, 2024. The number of employees increased by 787 or 16.15% compared to the previous year.
Employees
5,659
Change (1Y)
787
Growth (1Y)
16.15%
Revenue / Employee
1.77M HKD
Profits / Employee
-17.80K HKD
Market Cap
81.49B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Alibaba Health Information Technology | 1,435 |
Akeso | 3,035 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Sino Biopharmaceutical | 24,379 |
Innovent Biologics News
- 6 days ago - Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study ... - GuruFocus
- 6 days ago - Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema - PRNewsWire
- 7 days ago - Innovent Announces Oral Presentation of Full Phase 2 Clinical Data for Efdamrofusp Alfa (IBI302), First-in-class anti-VEGF/complement Bispecific Fusion Protein at ARVO 2025 - PRNewsWire
- 13 days ago - Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies - PRNewsWire
- 15 days ago - Innovent Biologics Inc (IVBIY) Showcases Groundbreaking Preclinical Data at AACR 2025 | IVBIY ... - GuruFocus
- 15 days ago - 2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific ... - GuruFocus
- 15 days ago - 2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs - PRNewsWire
- 17 days ago - Innovent Biologics Inc (IVBIY) Secures NMPA Approval for Limertinib as First-Line Treatment for ... - GuruFocus